Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

OPKO Health, Inc. (OPK) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

OPKO Health, Inc. (OPK), most recent 12 months reported: revenue $587.89M, net loss $72.89M, free cash flow -$134.02M. From SEC filings. Others in Pharmaceutical Preparations: NURIX THERAPEUTICS, INC. · ARROWHEAD PHARMACEUTICALS, INC. · Mirum Pharmaceuticals, Inc. · TRAVERE THERAPEUTICS, INC. · HutchMED (China) LIMITED · Vireo Growth Inc. · NATURE’S SUNSHINE PRODUCTS, INC. · ARCUTIS BIOTHERAPEUTICS, INC.

Stock screener

Watchlist